Prevention of Type I Diabetes and Recurrent ß-Cell Destruction of Transplanted Islets1
Robert H. Slover and
George S. Eisenbarth
Barbara Davis Center for Childhood Diabetes, University of Colorado
Health Sciences Center, Denver, Colorado 80262
I. Introduction
II. Disease Pathogenesis
III. Disease Prediction
A. Genetic prediction
B. Immunological prediction
C. Metabolicprediction
IV. Prevention of Type I Diabetes
A. Trial design
B. Genetic prevention
C. Prevention: preautoimmunity
D.Prevention: postautoimmunity/prediabetes
E. New onset patients/preventionof further ß-cell destruction
F. Pancreas and isletcell transplantation/prevention of recurrent
diabetes
G. Isletcell transplantation/prevention of ß-cell destruction
V. Conclusion
This article has been cited by other articles:
A. Hanukoglu, A. Mizrachi, I. Dalal, O. Admoni, Y. Rakover, Z. Bistritzer, A. Levine, E. Somekh, D. Lehmann, M. Tuval, et al. Extrapancreatic Autoimmune Manifestations in Type 1 Diabetes Patients and Their First-Degree Relatives: A multicenter study
Diabetes Care,
April 1, 2003;
26(4):
1235 - 1240.
[Abstract][Full Text][PDF]
C. Betterle, C. Dal Pra, F. Mantero, and R. Zanchetta Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction
Endocr. Rev.,
June 1, 2002;
23(3):
327 - 364.
[Abstract][Full Text][PDF]
I. Weets, I. H. De Leeuw, M. V.L. Du Caju, R. Rooman, B. Keymeulen, C. Mathieu, R. Rottiers, J.-C. Daubresse, D. Rocour-Brumioul, D. G. Pipeleers, et al. The Incidence of Type 1 Diabetes in the Age Group 0-39 Years Has Not Increased in Antwerp (Belgium) Between 1989 and 2000: Evidence for earlier disease manifestation
Diabetes Care,
May 1, 2002;
25(5):
840 - 846.
[Abstract][Full Text][PDF]
E. Bosi, S. Braghi, P. Maffi, M. Scirpoli, F. Bertuzzi, G. Pozza, A. Secchi, and E. Bonifacio Autoantibody Response to Islet Transplantation in Type 1 Diabetes
Diabetes,
November 1, 2001;
50(11):
2464 - 2471.
[Abstract][Full Text][PDF]
F. Winnock, M. R. Christie, M. R. Batstra, H.-J. Aanstoot, I. Weets, K. Decochez, P. Jopart, D. Nicolaij, and F. K. Gorus Autoantibodies to a 38-kDa Glycosylated Islet Cell Membrane-Associated Antigen in (Pre)type 1 Diabetes: Association with IA-2 and islet cell autoantibodies
Diabetes Care,
July 1, 2001;
24(7):
1181 - 1186.
[Abstract][Full Text][PDF]